Professional
Added to YB: 2024-10-01
Pitch date: 2024-08-08
DXCM [bullish]
DexCom, Inc.
+0.99%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$71.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
N/A
TCW Select Equities Fund Portfolio Holding: DexCom, Inc.
DXCM: Shares down on Stelo launch concerns. Mgmt's $40M 2024 sales est. for OTC 15-day CGM may be conservative. Thesis intact: strong product advantage in expanding market. Weakest performer in healthcare/consumer discretionary, but remain constructive despite volatility.
Read full article (1 min)